Here's some of what is coming soon to NeurologyLive® this week.
|Videos|July 20, 2016
Cognitive Decline Reversal in Alzheimer Disease
Author(s)Bobby Lazzara, MD
Dr. Bobby Lazzara discusses the first description of reversal of cognitive decline in early Alzheimer disease or its precursors.
Advertisement
Can cognitive decline in early Alzheimer disease or its precursors be reversed? In this Medical News Minute, developed exclusively for Neurology Times, Dr. Bobby Lazzara reviews
Advertisement
Related to this article
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending October 9, 2026.
Carmela Tartaglia, MD, FRCPC, discusses the challenges of diagnosing frontotemporal dementia, the evolving role of biomarkers, and emerging approaches to disease modification.
Catch up on any of the neurology headlines you may have missed in September 2026, compiled into 1 place by the NeurologyLive® team.
Carlos Cruchaga, PhD, director of the NeuroGenomics and Informatics Center at Washington University, discusses emerging blood-based biomarkers for monitoring biological and cognitive responses to lecanemab treatment in Alzheimer disease.
Here's some of what is coming soon to NeurologyLive® this week.
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending October 2, 2026.
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
ELEVIDYS Shows Sustained Functional Differences vs External Controls in Older Ambulatory Duchenne Patients
2
Dompé Begins Phase 2 Trial Testing Intranasal Nerve Growth Factor for Cerebral Palsy
3
The Road Ahead for Precision Medicine in Multiple Sclerosis
4
NeuroVoices: Ali Habib, MD, on Cemdisiran and the Phase 3 NIMBLE Trial Data in Myasthenia Gravis
5